OSTEOBLAST MEDIATED TURNOVER OF COLLAGENASE IN BONE
成骨细胞介导骨中胶原酶的周转
基本信息
- 批准号:3161091
- 负责人:
- 金额:$ 14.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-02-01 至 1995-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In some inherited disorders of the skeleton, including osteopetrosis and
osteosclerosis, excess bone accumulates whereas in osteoporosis bone loss
significantly exceeds bone gain. Historically, bone formation was
associated with the osteoblast and resorption with the osteoclast.
However, data has accumulated which indicates that the osteoblast takes an
active role in the resorption process. This cell has been shown to be the
primary target for a variety of resorption process. This cell has been
shown to be the primary target for a variety of resorption agents (e.g.,
parathyroid hormone, PTH, and 1, 25(OH)2D3) and to be capable of producing
neutral proteases, such as plasminogen activator and collagenase (C'ase).
We have recently shown that PTH stimulates secretion of the latter enzyme
by the rat osteoblastic cell line, UMR 106-01, with maximal concentrations
of C'ase appearing in the extracellular medium 12-24 h after addition of
the hormone. These subsequently decline becoming almost undetectable by 96
h. Further experiments revealed that the disappearance of previously
secreted enzyme was cell-mediated and suggested the action of a membrane
receptor for C'ase. We have now demonstrated the existence of such a
receptor on UMR cells which may be analogous to those reported for serine
proteases. These appear to be responsible for either activation and/or
endocytosis of the secreted enzyme. This has led us to formulate the
hypothesis that the C'ase receptor on osteoblastic cells is involved in the
regulation of the amounts of extracellular bone C'ase and that down-
regulation of such a moiety (e.g., by treatment of cells with PTH) may
dictate the abundance and function of the enzyme in the extracellular
milieu. Thus, the aims of the present proposal are to further characterize
the receptor and to test this hypothesis. These aims will be accomplished
by: 1) delineating the characteristics of the binding reaction, including
determining whether receptor number or affinity changes after PTH
treatment, 2) assessing the role of the receptor in the cell-mediated
turnover of the ligand, C'ase, and whether an alteration in the receptor
modifies this process, 3) determining the biochemical properties of the
receptor, both by cross-linking 125I-labelled C'ase to the receptor and by
125I-labelling the receptor, and finally, 4) using this information and
techniques to purify the receptor and obtain peptide sequence data. The
results of this work should aid in ascertaining the multiple sites of
regulation in the osteoblast of elaborated C'ase and shed some light on the
comprehensive role of this cell in the remodelling process (both matrix
synthesis and degradation). In so doing, the data should also provide some
insight into those many skeletal disorders where bone remodelling (?
aberrant C'ase expression/uptake) has gone awry.
在骨骼的一些遗传性疾病中,包括骨腐症和
骨硬化,过剩的骨积聚,而在骨质疏松症中,骨丢失
大大超过了骨骼的增长。从历史上看,骨形成是
与成骨细胞和破骨细胞的吸收有关。
然而,积累的数据表明,成骨细胞采取了
在吸收过程中发挥积极作用。该单元格已被显示为
主要目标为各种再吸收过程。这间牢房一直是
显示为各种再吸收试剂的主要目标(例如,
甲状旁腺激素、甲状旁腺激素和1,25(OH)2D3),并能够产生
中性蛋白酶,如纤溶酶原激活剂和胶原酶(C‘ase)。
我们最近发现,甲状旁腺素能刺激后一种酶的分泌。
最大浓度的大鼠成骨细胞系UMR 106-01
加入12-24小时后C‘酶出现在细胞外培养基中
荷尔蒙。随后,这些下降在96年变得几乎不可察觉
H.进一步的实验表明,之前的消失
分泌酶是由细胞介导的,提示是膜的作用。
C‘ase受体。我们现在已经证明了这样一个
UMR细胞上的受体,可能与已报道的丝氨酸类似
蛋白酶。它们似乎负责激活和/或
分泌酶的内吞作用。这导致我们制定了
假设成骨细胞上的C‘ase受体参与了
调节细胞外骨C‘酶的量,并下调-
对这种部分的调节(例如,通过用PTH处理细胞)可以
决定细胞外酶的丰度和功能
周围的环境。因此,本提案的目的是进一步说明
并检验这一假设。这些目标将会实现
通过:1)描述结合反应的特征,包括
甲状旁腺激素后受体数目或亲和力是否改变
治疗,2)评估受体在细胞介导的
配体、C‘酶的周转,以及受体是否发生变化
修改了这一过程,3)确定了
受体,既通过将~(125)I标记的C‘ase与受体交联,也通过
125I-标记受体,最后,4)使用该信息和
纯化受体和获得多肽序列数据的技术。这个
这项工作的结果应该有助于确定多个地点
精制C‘ase对成骨细胞的调节作用
该细胞在重塑过程中的全面作用(两者都是基质
合成和降解)。在这样做的时候,数据还应该提供一些
洞察许多骨骼疾病,其中骨骼重塑(?
异常C‘ase表达/摄取)出了问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicola C Partridge其他文献
Nicola C Partridge的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicola C Partridge', 18)}}的其他基金
Skyscan 1172 Ex-vivo MicroComputed Tomography System
Skyscan 1172 离体微型计算机断层扫描系统
- 批准号:
8446705 - 财政年份:2013
- 资助金额:
$ 14.28万 - 项目类别:
相似海外基金
DNA glycosylases involved in interstrand crosslink repair and antibiotic self-resistance
DNA糖基化酶参与链间交联修复和抗生素自身抗性
- 批准号:
2341288 - 财政年份:2024
- 资助金额:
$ 14.28万 - 项目类别:
Standard Grant
CAREER: Uncovering Mechanisms of DNA-protein Crosslink Repair
职业:揭示 DNA-蛋白质交联修复机制
- 批准号:
2335208 - 财政年份:2023
- 资助金额:
$ 14.28万 - 项目类别:
Continuing Grant
Investigating the molecular mechanism of SNM1A nuclease in DNA interstrand crosslink repair
研究SNM1A核酸酶在DNA链间交联修复中的分子机制
- 批准号:
548157-2020 - 财政年份:2022
- 资助金额:
$ 14.28万 - 项目类别:
Postgraduate Scholarships - Doctoral
CAREER: Uncovering Mechanisms of DNA-protein Crosslink Repair
职业:揭示 DNA-蛋白质交联修复机制
- 批准号:
2146384 - 财政年份:2022
- 资助金额:
$ 14.28万 - 项目类别:
Continuing Grant
A molecular and structural approach to understanding interstrand crosslink incision by the Fanconi anaemia DNA repair pathway
通过分子和结构方法了解 Fanconi 贫血 DNA 修复途径的链间交联切口
- 批准号:
MR/X000192/1 - 财政年份:2022
- 资助金额:
$ 14.28万 - 项目类别:
Research Grant
Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair
SPRTN 蛋白酶的调节和 SPRTN 介导的 DNA-蛋白质交联修复
- 批准号:
10446610 - 财政年份:2022
- 资助金额:
$ 14.28万 - 项目类别:
Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair
SPRTN 蛋白酶的调节和 SPRTN 介导的 DNA-蛋白质交联修复
- 批准号:
10641893 - 财政年份:2022
- 资助金额:
$ 14.28万 - 项目类别:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10438886 - 财政年份:2021
- 资助金额:
$ 14.28万 - 项目类别:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10296087 - 财政年份:2021
- 资助金额:
$ 14.28万 - 项目类别:
Investigating the molecular mechanism of SNM1A nuclease in DNA interstrand crosslink repair
研究SNM1A核酸酶在DNA链间交联修复中的分子机制
- 批准号:
548157-2020 - 财政年份:2021
- 资助金额:
$ 14.28万 - 项目类别:
Postgraduate Scholarships - Doctoral